Carbamazepine replacement of phenytoin, phenobarbital and primidone in a rehabilitation setting: effects on seizure control

References

• Trimble M. R., Reynolds E. H. Anticonvulsant drugs and mental symptoms. Psychological Medicine 1976; 6: 169–178
   PubMed Web of Science ®Google Scholar
• Reynolds E. H., Trimble M. R. Adverse neuropsychiatric effects of anticonvulsant drugs. Drugs 1985; 29: 570–581
   PubMed Web of Science ®Google Scholar
• Oles K. S., Penry J. K. Pharmacological prophylaxis of post-traumatic seizures. Current Therapy in Neurologic Disease, R. T. Johnson. B.C. Decker, Ontario 1985; 46–50
   Google Scholar
• Thompson P. J., Trimble M. R. Anticonvulsant drugs and cognitive functions. Epilepsia 1982; 23: 531–544
   PubMed Web of Science ®Google Scholar
• Thompson P. J., Huppert F. A., Trimble M. R. Phenytoin and cognitive functions: effects on normal volunteers and implications for epilepsy. British Journal of the Society of Clinical Psychology 1981; 20: 155–162
   Google Scholar
• Dodrill C. B., Troupin A. S. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 1977; 27: 1023–1028
   PubMed Web of Science ®Google Scholar
• Trimble M. R., Corbett J. A. Behavioral and cognitive disturbances in epileptic children. Irish Medical Journal 1980; 73 (Suppl): 21–28
   Google Scholar
• Andrewes D. G., Tomlinson L., Elwes R. D.C., et al. The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy. Acta Neurologica Scandinavia 1984; 69 (Suppl 99): 23–30
   Web of Science ®Google Scholar
• Andrewes D. G., Bullen J. G., Tomlinson L., et al. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia 1986; 27 (2): 128–134
   Web of Science ®Google Scholar
• Jennett B., Teather D., Bennie S. Epilepsy after head injury. Lancet. 1973; 652–653
   Google Scholar
• Jennett B., . Post-traumatic epilepsy. Editors. Rehabilitation of the Head Injured Adult, E. R. Griffith, M. R. Bond, M. Rosenthal, F. A. Davis, et al, Philadelphia 1983; 119–124
   Google Scholar
• Guelen J.M P., Van Der Kleijn E., Woodbury J. K. Practical pharmacokinetics. Antiepileptic Drugs, D. M. Penry, C. E. Pippenger. Raven Press, New York 1982; 57–71
   Google Scholar
• Hoppener R. J., Kuyer A., Meijer J. W.A., et al. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects. Epilepsia 1980; 21: 341–350
   PubMed Web of Science ®Google Scholar
• Rapeport W. G. Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy. Clinical Neuropharmacology 1985; 8: 141–149
   PubMed Web of Science ®Google Scholar
• Caveness W. F., Meirowsky A. M., Rish B. L., et al. The nature of posttraumatic epilepsy. Journal of Neurosurgery 1979; 50: 545–553
   PubMed Web of Science ®Google Scholar
• Jick H., Dinan B. J., Hunter J. R., et al. Tricyclic antidepressants and convulsions. Journal of Clinical Psychopharmacy 1983; 3: 182–185
   PubMed Web of Science ®Google Scholar
• Edwards J. G., Long S. K., Sedgwick E. M., et al. Antidepressants and convulsive seizures: clinical electro-encephalographic and pharmacological aspects. Clinical Neuropharmacology 1986; 9: 329–360
   PubMed Web of Science ®Google Scholar
• Glenn M. B., Wroblewski B. A. Anticonvulsants for prophylaxis of post-traumatic seizures. Head Trauma Rehabilitation 1986; 1 (1): 73–74
   Google Scholar
• Reynolds E. H., Travers R. D. Serum anticonvulsant concentrations in epileptic patients with mental symptoms. British Journal of Psychiatry 1974; 124: 440–445
   PubMed Web of Science ®Google Scholar
• Thompson P. J., Trimble M. R. Anticonvulsant serum levels: relationship to impairment of cognitive functioning. Journal of Neurological Neurosurgery and Psychiatry 1983; 46: 227–233
   PubMed Web of Science ®Google Scholar
• Hutt S. J., Jackson P. M., Belsham A., et al. Perceptual-motor behavior in relation to blood phenobarbital level: a preliminary report. Development Medical Child Neurology 1968; 10: 626–632
   PubMed Web of Science ®Google Scholar
• Camfield C. S., Chaplin S., Doyle A., et al. Side effects of phenobarbital in toddlers: behavioral and cognitive aspects. Pediatrics 1979; 95: 361–365
   Web of Science ®Google Scholar
• Wolfe S. M. Forsythe, A: Behavior disturbances, phenobarbital and febrile seizures. Pediatrics 1978; 61: 728–731
   PubMed Web of Science ®Google Scholar
• McGowan M. E.L., Neville B. G.R., Reynolds E. H. Comparative monotherapy trial in children with epilepsy. British Journal of Clinical Practice 1983; 27 (Suppl): 115–118
   Google Scholar
• Ludgate J., O'Keating J., Dwyer R., et al. An improvement in cognitive function following polypharmacy reduction in a group of epileptic patients. Acta Neurological Scandinavia 1985; 71: 448–452
   PubMed Web of Science ®Google Scholar
• Mattson R. H., Cramer J. A., Collins J. F., et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine 1985; 313: 145–151
   PubMed Web of Science ®Google Scholar
• Hart R. G., Easton J. D. Carbomazepine and hematological monitoring. Annals of Neurology 1982; 11: 309–213
   PubMed Web of Science ®Google Scholar